Health
As a doctor who practiced medicine in Pennsylvania for over 25 years, Dr. Joyce came to Congress to improve Pennsylvanians' access to quality and affordable health care. From protecting Medicare and investing in American medical innovation to combating the drug crisis and strengthening the pipeline of doctors entering our community through his Homegrown Health Care Initiative, Dr. Joyce is fighting every day to make our health care system work better for American patients.
More on Health
Chambersburg, PA ? Today, Congressman John Joyce, M.D. (PA-13) hosted White House Office of National Drug Control Policy (ONDCP) Director Jim Carroll for two roundtables in central Pennsylvania to discuss our nation's drug crisis, which has taken a tangible toll on our community.
13th District Health Care Leaders Praise Initiative
Congressman John Joyce (PA-13) today introduced bipartisan legislation to reduce the costs of prescription drugs by making generic medicine more quickly accessible to consumers. Joyce teamed up on the Ensuring Timely Access to Generics Act of 2019 with Anthony Brindisi (D-NY) and the companion version of the bill was introduced in the Senate earlier this April by Sen. Cory Gardner (R-CO), Sen. Jeanne Shaheen (D-NH) and Sen. Bill Cassidy (R-LA).
Congressman John Joyce, M.D. (PA-13) released the following statement on H.R. 19, the Lower Costs, More Cures Act of 2019.
"As a physician serving in Congress, I am working to improve Americans' access to quality and affordable health care. Lowering prescription drug costs is a bipartisan priority, and Speaker Pelosi's politically-driven H.R. 3 is not the answer. This innovation-stifling legislation would prevent 100 new cures from reaching American patients and lacks the support needed to become law.
Congressman John Joyce, M.D. (PA-13) today emphasized the Chinese Communist Party's coverup of the coronavirus outbreak and outlined his work on the China Task Force to hold this hostile regime accountable. Watch his full remarks on the House Floor.
During today's House Homeland Security Committee hearing Secretary Kirstjen Nielsen testified to Congressman John Joyce (PA-13) that additional physical barriers are necessary to stop the flow of illegal drugs into the country and combat the drug epidemic in Pennsylvania.
Watch Joyce's exchange with Nielsen HERE.
TRANSCRIPT
House Democrats today voted to pass H. Res 430, legislation to give them further authority to continue their efforts to relitigate the Mueller Investigation. The resolution, passed entirely on party lines, will allow the House Judiciary Committee and other House panels to enforce its subpoenas on Trump administration officials such as Attorney General William Barr and former White House counsel Don McGahn.
The Washington Examiner today published a profile of Congressman John Joyce (PA-13), highlighting how his medical background prompted him to run for Congress and how his first-hand knowledge of the health care industry has influenced the legislation he has worked on during his first term. The Pennsylvania lawmaker and former physician discussed his new bipartisan legislation to make generic drugs more accessible for patients and some of his broader beliefs about the future of health care. Some highlights from the story can be found below.
***
Today, members of the Pennsylvania Republican Congressional Delegation, including Congressman John Joyce, M.D., GT Thompson, Congressman Mike Kelly, Congressman Scott Perry, Congressman Lloyd Smucker, Congressman Guy Reschenthaler, Congressman Dan Meuser, and Congressman Fred Keller, made the following statement following a briefing conducted for their offices by the Pennsylvania Attorney General's office:
Today, Reps. Phil Roe, M.D. (R-TN), Buddy Carter (R-GA), Andy Harris, M.D. (R-MD), Ralph Abraham, M.D. (R-LA), Larry Bucshon, M.D. (R-IN), Scott DesJarlais, M.D. (R-TN), Neal Dunn, M.D. (R- FL), John Joyce, M.D. (R-PA) released the following statements after sending a letter to the U.S.
Congressman John Joyce (PA-13) today announced that he will cosponsor legislation this week to repeal the 2.3 percent medical device tax before it is reinstated for the 2020 calendar year. The tax, which was first implemented in 2013 as an effort to help fund the subsidies in the Affordable Care Act, applies to the price of medical devices large and small, including anything from MRI machines to surgical gloves. Lawmakers of both parties have voted multiple times since 2015 to temporarily halt the tax due to the problems it has caused patients and providers in the healthcare industry.